Drug Profile
Myoseal
Latest Information Update: 30 Mar 2007
Price :
$50
*
At a glance
- Originator Molecular Targeting Technologies
- Class
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Myocardial infarction
Most Recent Events
- 21 Nov 2001 Preclinical development for Myocardial infarction in USA (Unknown route)